The sale of venture-backed Belgian biopharmaceutical company Okapi Sciences to listed US biopharma Aratana Therapeutics highlights the benefits that come from maintaining relationships with former fellow investors.
Sabina Wizander returns to Creandum as partner after spending four years at portfolio company Kry
Media report values the business at $1.16bn, with the two GPs buying their stake for $600m
Listing of the open-source enterprise software business is expected on 19 May 2021
Hydraulic cylinder producer is the third deal of 2021 from the GP's Enact strategy